We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novo Nordisk Gearing Up to Double Down on Diabetes Drugs in 2013
Novo Nordisk Gearing Up to Double Down on Diabetes Drugs in 2013
February 7, 2013
Novo Nordisk, flush with cash and confidence after a lucrative 2012, plans to double down on its booming diabetes business this year in anticipation of two pending drug approvals and with high hopes for last-stage advancement of a promising new GLP-1 treatment.